strated concentrations comparable to those in serum. This led to the therapeutic decision to manage the patient by dialysis. Subsequently, serum samples collected during the course of hospitalization were analyzed quantitatively by gas-liquid chromatography for methsuximide, Ndesmethylmethsuximide, primidone, phenobarbital, and diphenylhydantoin.
Selected serum specimens were also analyzed by gas chromato9raphy-mass spectrometry, and N-methyl-2-hydroxymethyl-2-phenylsuccinimide, a metabolite of methsuximide not previously described in human serum, was identified by analysis of its mass spectrum. Several of these drugs are metabolized to compounds that also possess anticonvulsant activity or produce symptoms of central nervous system toxicity. In such circumstances, both the parent drug and its pharmacologically active metabolite (s) should be quantitated. Primidone and methsuximide, commonly used to manage various types of seizures, are converted to active and to phenylethylmalonamide, for which the pharmacologic activity in man is not yet established (4).
Cases of acute overdosage with primidone (5, 6) and with methsuximide (7) have been reported and each drug, under this circumstance, produces profound central nervous system depression. Combined massive, fatal overdosage with these two drugs, such as occurred in the patient reported here, has not been described previously.
We measured serum concentrations of these drugs and metabolites during the course of her hospitalization, which included management with both peritoneal and hemodialysis. In addition, the availability of sequential specimens from this unique case provided us with an opportunity to investigate further the metabolism of methsuximide and primidone, which we did by gas chromatography-mass spectrometry.
Case History
A 29-year-old unconscious white woman was admitted to the Emergency Room of The Johns Hopkins Hospital on March 28, 1975. She had a 10-year history of seizures and during the eight years before admission had been treated with diphenylhydantoin, phenobarbital, and primidone.
In August 1973, her neurological status was re-evaluated because of occasional absence seizures, and methsuximide was added to the therapeutic regimen. She was also noted to have an abnormal glucose-tolerance test and was treated by dietary restriction in addition to tolbutamide.
During the month before admission, the patient became progressively more depressed and required She remained depressed however, and was seen regularly by a psychiatrist.
On the evening prior to admission the patient complained of general malaise and had a syncopal episode. Although she awoke later in the evening, she had difficulty walking and acted as if she were intoxicated; she then returned to bed and became unresponsive.
Twelve hours later she could not be aroused and was brought to the Emergency Room.
Vital She was first treated with norepinephrine and thereafter she was maintained on dopamine. Because of her hypotension, peritoneal dialysis was begun; however, when her blood pressure stabilized, a shunt was created between her right femoral artery and saphenous vein, and she subsequently underwent two periods of hemodialysis.
Her course was characterized by persistent bleeding from the shunt, which necessitated massive transfusion therapy. On the third hospital day, her pupils reacted to light for the first time, and a slight cold caloric reflex was noted. The next day neurological examination showed spontaneous extra-ocular movements and positive corneal reflexes; however, the patient remained flaccid without spontaneous move-
ments.
Her level of consciousness did not improve and on the fifth hospital day she had two cardiac arrests and marked hypotension recurred that required pressor therapy. Thereafter her course was further complicated by Gram-negative sepsis and disseminated intravascular coagulation, and she expired on the eleventh hospital day. 16801). The injector temperature was 250 #{176}C, the detector was 300 #{176}C and the oven temperature was programmed 150-270 #{176}C at 16 #{176}C/min.
Materials and Methods

Comparison Materials
Gas-Chromatographic
Method for Other Anticonvulsant Determinations
Analyses of diphenylhydantoin, phenobarbital and primidone were performed by on-column methylation according to the method of Kananen et al. (8) .
Gas Chromatography-Mass
Spectrometric-Computer Analysis
For electron ionization mass spectra, we used a Model 5784A gas chromatograph equipped with a heated oncolumn injection port, interfaced through a membrane separator to a Model 5982A GC/MS system with a dodecapole analyzer, and coupled to a 5933A data system (all from Hewlett-Packard).
The gas-chromatographic column was glass, 360 cm X 2 mm i.d., packed with 0.25% neopentyl glycol succinate plus 0.025% phosig N-Desmethylmefhsuximide ditions: no separator was used, methane was used as both carrier and ionizing reagent gas, and spectra were recorded at an ionizing voltage of 300 eV and an emission current of 200 uA.
Results and Discussion
Controls and standards. and therefore we conducted a more detailed investigation by use of combined gas chromatography-mass spectrometry (GC/MS). Three samples of serum were chosen for analysis by GC/MS: one obtained at the time of admission, a second 24 h after admission, and the third at 36 h. Ethyl acetate extracts of these sera were injected on column without derivatization. During the elution of the components from the column, the mass spectrometer was scanned approximately every 2 s through a 40-400 range of mie and the data were stored on the computer for subsequent analysis.
The mass intensities were summed for each spectrum and then normalized to produce a reconstructed chromatogram ( Figure 6 ) analogous to the response from a flame-ionization detector on a gas chromatograph.
The three extracted serum samples analyzed in this manner showed similar peaks in their total-abundance chromatograms; however, the peak heights differed N-D.s.n,thykn.thsu,,mide   A   ,,,.,,,,, , n , ,, amination of the total mass spectra of these peaks indicate that both compounds have a molecular weight of 219.
An ethyl acetate solution of p -hydroxyphenylmethsuximide, one of the known methsuximide metabolites, was injected into the GC/MS and its retention time and mass spectrum were compared to those for components B and H. Component H was thus determined to be phydroxyphenylmethsuximide.
If component B was also a metabolite of methsuximide, one of three structures was probable:
N-methyl-2-hydroxymethyl-2-phenylsuccinimide, N,2-dimethyl-2-phenyl-3-hydroxysuccinimide, or N-hydroxymethyl-2-methyl-2-phenylsuccinimide.
The first two of these compounds have previously been reported as urinary metabolites of methsuximide in the rat, guinea pig, and human (13). The N-hydroxymethyl compound was ruled out by the intense rn/c 134, which is attributable to loss of the -CONCH3CO-moiety similar to methsuximide itself.
A tentative identification of component B as Nmethyl-2-hydroxymethyl-2-phenylsuccinimide is based on the intense rn/c 132 ion, which corresponds to the molecular ion of 2-phenyl propenal formed by the loss of hydrogen from the 134 ion.
Because of the large amount of N-desmethylmethsuximide present in the patient's serum, we also Figure 8 . Because the process of chemical ionization involves a low energy transfer of a proton, the mass spectra show very little fragmentation, with the largest peak usually being the protonated molecular ion (MW), peaks appeaning at M+29 (M+C2H5) and M+41 (M+C3H5) are also common when methane is used as the reagent gas (14).
Component D (Figure 6 ) was compared to authentic tolbutamide and to p -toluenesulfonamide, Component J was identified, from its mass spectrum, as cholesterol.
Component G appears to have a molecular weight of 228. The base peak of its electron ionization spectrum is 130; however, this material has not been identified.
The very minor components K and M appear to be steroidal type compounds.
Diphenylhydantoin was detected in trace amounts by plotting the single-ion chromatogram of the molecular ion.
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